المؤلفون: A V Glotov, T N Fedorova, V V Goltyapin, V A Akhmedov

المصدر: Терапевтический архив, Vol 89, Iss 12, Pp 28-33 (2017)

مصطلحات موضوعية: obstructive sleep apnea syndrome, saturation, ent pathology, obesity, variance factor analysis, Medicine

وصف الملف: electronic resource

Relation: https://ter-arkhiv.ru/0040-3660/article/view/32303; https://doaj.org/toc/0040-3660; https://doaj.org/toc/2309-5342

URL الوصول: https://doaj.org/article/20f936fa54624770bc71c2893d428fe1

المؤلفون: Yu A Stepanova, S A Grishankov, N A Karelskaya, D V Kalinin, A V Glotov

المصدر: Клиническая практика, Vol 7, Iss 2, Pp 58-66 (2016)

مصطلحات موضوعية: retroperitoneal schwannoma, complexity of diagnosis, treatment, Medicine

وصف الملف: electronic resource

Relation: https://journals.eco-vector.com/clinpractice/article/viewFile/8100/6522; https://doaj.org/toc/2220-3095; https://doaj.org/toc/2618-8627

URL الوصول: https://doaj.org/article/240d7ce336524872a73510580ddca529

المؤلفون: Tat'yana Nikolaevna Fedorova, Andrey Vasil'evich Glotov, Vladimir Grigor'evich Demchenko, T N Fedorova, A V Glotov, V G Demchenko

المصدر: Терапевтический архив, Vol 82, Iss 3, Pp 32-36 (2010)

مصطلحات موضوعية: efficiency, rehabilitation, chronic obstructive pulmonary disease, occupational bronchitis, disability, Medicine

وصف الملف: electronic resource

Relation: https://ter-arkhiv.ru/0040-3660/article/view/30551; https://doaj.org/toc/0040-3660; https://doaj.org/toc/2309-5342

URL الوصول: https://doaj.org/article/619253261368420eb15395365b34978b

المؤلفون: Kh. A. Ayvazyan, E. D. Kuzminikh, T. V. Shevchenko, Yu. A. Stepanova, O. I. Zhavoronkova, D. A. Ionkin, V. S. Shirokov, A. V. Glotov, B. N. Gurmikov, A. V. Zhao

المصدر: Кубанский научный медицинский вестник, Vol 29, Iss 6, Pp 67-83 (2022)

مصطلحات موضوعية: hepatic cysts, biliary cystadenoma, biliary cystadenocarcinoma, mucinous cystadenoma, diagnosis, treatment, hepatectomy, Medicine

وصف الملف: electronic resource

Relation: https://ksma.elpub.ru/jour/article/view/2900; https://doaj.org/toc/1608-6228; https://doaj.org/toc/2541-9544

URL الوصول: https://doaj.org/article/5304dc848b274341b5ae412d4837caa9

المؤلفون: Yu. A. Stepanova, A. V. Glotov, V. S. Shirokov, A. A. Kovalenko, S. V. Sapelkin, E. A. Akhtanin, A. N. Lednev, Ю. А. Степанова, А. В. Глотов, В. С. Широков, А. А. Коваленко, С. В. Сапелкин, Е. А. Ахтанин, А. Н. Леднев

المصدر: Medical Visualization; Том 28, № 1 (2024); 120-140 ; Медицинская визуализация; Том 28, № 1 (2024); 120-140 ; 2408-9516 ; 1607-0763

مصطلحات موضوعية: МСКТ, prevalence, morphology, diagnostics, ultrasound, MSCT, распространенность, морфология, диагностика, УЗИ

وصف الملف: application/pdf

Relation: https://medvis.vidar.ru/jour/article/view/1356/851; https://medvis.vidar.ru/jour/article/downloadSuppFile/1356/2137; Takei T.R., Nalebuff E.A. Extradigital glomus tumour. J. Hand. Surg. Br. 1995; 20 (3): 409–412. http://doi.org/10.1016/s0266-7681(05)80105-6; White C.P., Jewer D.D. Atypical presentation of a glomus tumour: A case report. Can. J. Plast. Surg. 2006; 14 (4): 237–238. http://doi.org/10.1177/229255030601400402; Wood W. On painful subcutaneous tubercle. Edinburgh Med. J. 1812; 8: 283.; Masson P. Le glomus neuromyoartérial des régions tactiles et ses tumeurs. Lyon Chir. 1924; 21: 257–280.; Gombos Z., Zhang P.J. Glomus tumor. Arch. Pathol. Lab. Med. 2008; 132 (9): 1448–1452. http://doi.org/10.5858/2008-132-1448-GT; Fletcher C.D.M. World Health Organization, International Agency for Research on Cancer. WHO Classification of Tumours of Soft Tissue and Bone. 4. Lyon, France: IARC Press, 2013.; Akgün R.C., Güler U.Ö., Onay U. A glomus tumor anterior to the patellar tendon: a case report. Acta Orthop. Traumatol. Turc. 2010; 44 (3): 250–253. http://doi.org/10.3944/AOTT.2010.2174; Abela M., Cole A.S., Hill G.A., Carr A.J. Glomus tumor of the scapular region. J. Shoulder Elbow. Surg. 2000; 9 (6): 532–533. http://doi.org/10.1067/mse.2000.108961; Negri G., Schulte M., Mohr W. Glomus tumor with diffuse infiltration of the quadriceps muscle: a case report. Hum. Pathol. 1997; 28 (6): 750–752. http://doi.org/10.1016/s0046-8177(97)90188-x; Wang Y., Li T., Lv Z. et al. Glomus tumors around or in the knee: a case report and literature review. BMC Surg. 2022; 22 (1): 97. http://doi.org/10.1186/s12893-022-01545-8; Stacy G.S., Cipriani N.A. Glomus tumours of the knee: a case series. Clin. Radiol. 2023; 78 (2): e123–e130. http://doi.org/10.1016/j.crad.2022.09.125; Stumpf N., Huang S., Pritchett E., Lee J. Glomangioma of the elbow. Dermatol. Online J. 2021; 27 (6). http://doi.org/10.5070/D327654064; Constantinidis J., Kiefer A., Reitnauer K., Iro H. Glomangioma of the nasal cavity and paranasal sinuses. Rhinology. 2000; 38 (3): 136–139.; Panickar N., Tara V.S. Rare and Atypical Presentation of Glomus Tumor in the Eyelid. Korean J. Ophthalmol. 2021; 35 (2): 171–172. http://doi.org/10.3341/kjo.2020.0113; Jing H., Weiwen C., Meihong C., Xiaohong G. Glomus tumour of the iris: A case report. Eur. J. Ophthalmol. 2022; 32 (1): NP203–NP207. http://doi.org/10.1177/1120672120959030; Bauerová L., Gabris V., Honsová E., Povýsil C. Glomus tumor of the stomach: a case report and review of the literature. Cesk Patol. 2011; 47 (3): 128–129.; Deng M., Luo R., Huang J. et al. Clinicopathologic features of gastric glomus tumor: A report of 15 cases and literature review. Pathol. Oncol. Res. 2023; 28: 1610824. http://doi.org/10.3389/pore.2022.1610824; Amoueian S., Meibodi N.T., Tavoosi H. et al. Primary glomus tumor of the liver. Arch. Iran Med. 2011; 14(4): 294–295.; Al-Ahmadie H.A., Yilmaz A., Olgac S., Reuter V.E. Glomus tumor of the kidney: a report of 3 cases involving renal parenchyma and review of the literature. Am. J. Surg. Pathol. 2007; 31 (4): 585–591. http://doi.org/10.1097/01.pas.0000213373.64053.41; Hu Y., He X., Zhang Q. et al. Primary Adrenal Glomus Tumor: The First Case Report. Urol. Int. 2022; 106 (3): 317–320. http://doi.org/10.1159/000519482; Shah T.S., Paton A. A catecholamine secreting retroperitoneal glomangioma. A case report. East Afr. Med. J. 1973; 50 (10): 586–593.; Dalfior D., Parisi A., Cannizzaro C. et al.Pulmonary glomus tumor. Int. J. Surg. Pathol. 2008; 16 (1): 81–84. http://doi.org/10.1177/1066896907304520; Wang S., Ding C., Tu J. Malignant glomus tumor of the lung with multiple metastasis: a rare case report. Wld J. Surg. Oncol. 2015; 13: 22. http://doi.org/10.1186/s12957-014-0423-3; Menaissy Y.M., Gal A.A., Mansour K.A. Glomus tumor of the trachea. Ann. Thorac. Surg. 2000; 70 (1): 295–297. http://doi.org/10.1016/s0003-4975(00)01285-6; Péricart S., Chiariello G.A., Massiere J. et al. Tumeur glomique intracardiaque: une tumeur péricytaire (périvasculaire) de localisation inhabituelle [Cardiac glomus tumor: An unusual localization of pericytic (perivascular) tumor]. Ann. Pathol. 2021; 41 (6): 561–566. http://doi.org/10.1016/j.annpat.2021.06.007 (In French); Yalcin S., Ergul E., Ucar A.E. et al. Glomus tumor of the breast: first report. Langenbecks Arch. Surg. 2009; 394 (2): 399–400. http://doi.org/10.1007/s00423-008-0337-z; Barajas D. Glomus tumor of the male breast. Breast J. 2020; 26 (2): 297–298. http://doi.org/10.1111/tbj.13549; Tullie S.T.E., Quraishi M.K., Karawita T., Anjarwalla S. Rare presentation of a testicular glomus tumour. BMJ Case Rep. 2019; 12 (11): e230935. http://doi.org/10.1136/bcr-2019-230935; Tsang J.C.H., Ng C.S., Fung C.F. et al. Glomus Tumor of Sella Turcica With Synaptophysin Expression Mimicking Pituitary Adenoma. Int. J. Surg. Pathol. 2020; 28 (4): 401–405. http://doi.org/10.1177/1066896919900550; Michal M. Glomus tumour with intravascular spread. Cesk. Patol. 1993; 29 (4): 144–146.; Acebo E., Val-Bernal J.F., Arce F. Giant intravenous glomus tumor. J. Cutan. Pathol. 1997; 24 (6): 384–389. http://doi.org/10.1111/j.1600-0560.1997.tb00808.x; Beaton L.E., Davis L. Glomus tumor. Q. Bull. Northwest. Univ. Med. Sch. 1941; 15: 245–254.; Chiang E.R., Chen T.H. Multiple glomus tumors in gastrocnemius muscle: a case report. Arch. Orthop. Trauma Surg. 2008; 128 (1): 29–31. http://doi.org/10.1007/s00402-007-0377-9; Folpe A.L., Fanburg-Smith J.C., Miettinen M., Weiss S.W. Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am. J. Surg. Pathol. 2001; 25 (1): 1–12. http://doi.org/10.1097/00000478-200101000-00001; Cabral R., Santiago F., Tellechea O. Multiple glomus tumors and segmental neurofibromatosis: there are no coincidences. Dermatol. Online J. 2011; 17 (3): 4.; Blume-Peytavi U., Adler Y.D., Geilen C.C. et al. Multiple familial cutaneous glomangioma: a pedigree of 4 gener ations and critical analysis of histologic and genetic differences of glomus tumors. J. Am. Acad. Dermatol. 2000; 42; 633–639.; Enzinger F.M., Weiss S.W. (eds).: Perivascular tumors. In: Soft Tissue Tumors. 4th ed. Mosby, St.Louis, 2001: 985– 1001.; Mravic M., LaChaud G., Nguyen A. et al. Clinical and histopathological diagnosis of glomus tumor: an institutional experience of 138 cases. Int. J. Surg. Pathol. 2015; 23 (3): 181–188. http://doi.org/10.1177/1066896914567330; Riddell D.H., Martin R.S. Glomus tumor of unusual size; case report. Ann. Surg. 1951; 133 (3): 401–403. http://doi.org/10.1097/00000658-195103000-00015; Rao A.G., Indira D., Kamal J. Extra digital glomangioma. Indian J. Dermatol. 2010; 55 (4): 397–398. http://doi.org/10.4103/0019-5154.74570; Porter P.L., Bigler S.A., McNutt M., Gown A.M. The immunophenotype of hemangiopericytomas and glomus tumors, with special reference to muscle protein expression: an immunohistochemical study and review of the literature. Mod. Pathol. 1991; 4 (1): 46–52.; Watanabe K., Kusakabe T., Hoshi N. et al. h-Caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: its specific expression in the smooth muscle cell tumor. Hum. Pathol. 1999; 30 (4): 392–396. http://doi.org/10.1016/s0046-8177(99)90113-2; Chen J.H., Lin L., Liu K.L. et al. Malignant glomus tumor of the intestinal ileum with multiorgan metastases: A case report and review of literature. Wld J. Gastroenterol. 2020; 26 (7): 770–776. http://doi.org/10.3748/wjg.v26.i7.770; Xie Q., Xia Y., Zhang J., Zhu J.M. A glomus tumor with intravascular spread and multiple metastases: A case report. Asian J. Surg. 2023; 46 (2): 1099–1100. http://doi.org/10.1016/j.asjsur.2022.07.134; Guvendir I., Zemheri I.E., Altundal K. et al. Ossified uncertain malignant potential gastric glomus tumor with tumor thrombus. Indian J. Pathol. Microbiol. 2021; 64 (2): 369–372. http://doi.org/10.4103/IJPM.IJPM_374_20; Cooke S.A. Misleading features in the clinical diagnosis of the peripheral glomus tumour. Br. J. Surg. 1971; 58 (8): 602–606. http://doi.org/10.1002/bjs.1800580817; Varian J.P., Cleak D.K. Glomus tumours in the hand. Hand. 1980; 12 (3): 293–299. http://doi.org/10.1016/s0072-968x(80)80056-8; Lopes T.D., Rotman M.B., Levy B.K., Gilula L.A. A 63-yearold woman with right small finger pain. Am. J. Orthop. (Belle Mead NJ). 1997; 26 (2): 169–171.; Van Geertruyden J., Lorea P., Goldschmidt D. et al. Glomus tumours of the hand. A retrospective study of 51 cases. J. Hand Surg. Br. 1996; 21 (2): 257–260.; Vasisht B., Watson H.K., Joseph E., Lionelli G.T. Digital glomus tumors: a 29-year experience with a lateral subperiosteal approach. Plast. Reconstr. Surg. 2004; 114 (6): 1486–1489. http://doi.org/10.1097/01.prs.0000138752.36175.d5; Carroll R.E., Berman A.T. Glomus tumors of the hand: review of the literature and report on twenty-eight cases. J. Bone Jt Surg. Am. 1972; 54 (4): 691–703.; Rettig A.C., Strickland J.W. Glomus tumor of the digits. J. Hand Surg. Am. 1977; 2 (4): 261–265. http://doi.org/10.1016/s0363-5023(77)80121-4; Mansat M., Bonnevialle P., Gay R., Durroux R. Tumeurs glomiques de la main: A propos de quatorze cas. [Glomus tumors of the hand: Presentation of fourteen cases]. Ann. Chir. de la Main. 1985; 4 (1): 43–50. http://doi.org/10.1016/S0753-9053(85)80081-8; Gandon F., Legaillard P., Brueton R. et al. Forty-eight glomus tumours of the hand. Retrospective study and four-year follow-up. Ann. Chir. Main. Memb. Super. 1992; 11 (5): 401–405. http://doi.org/10.1016/s0753-9053(05)80277-7; Arkwright S., Bachar M., Vilde F. Tumeurs glomiques. Etude clinique, histologique et immunohistochimique. A propos de vingt-neuf cas [Glomus tumors. Clinical, histological and immunohistochemical study. Apropos of 29 cases]. Arch. Anat. Cytol. Pathol. 1996; 44 (4): 160–165.; Kim S.-H., Suh H.-S., Choi J.-H. et al. Glomus Tumor: a Clinical and Histopathologic Analysis of 17 Cases. Ann. Dermatol. 2000; 12 (2): 95. http://doi.org/10.5021/ad.2000.12.2.95; Assmus H., Dombert T. Zur Lokalisation und operativen Behandlung der Glomustumoren der Extremitäten. Bericht über 36 Fälle [Glomus tumours of the extremities: localisation and operative treatment in 36 cases]. Handchir. Mikrochir. Plast. Chir. 2002; 34 (2): 103–107. German. http://doi.org/10.1055/s-2002-32308; Schiefer T.K., Parker W.L., Anakwenze O.A. et al. Extradigital glomus tumors: a 20-year experience. Mayo Clin. Proc. 2006; 81 (10): 1337–1344. http://doi.org/10.4065/81.10.1337; Frikh R., Alioua Z., Harket A. et al. Tumeurs glomiques: étude anatomoclinique de 14 cas avec revue de littérature [Glomus tumors: anatomoclinical study of 14 cases with literature review]. Ann. Chir. Plast. Esthet. 2009; 54 (1): 51–56. http://doi.org/10.1016/j.anplas.2008.05.001 (In French); Lee D.W., Yang J.H., Chang S. et al. Clinical and pathological characteristics of extradigital and digital glomus tumours: a retrospective comparative study. J. Eur. Acad. Dermatol. Venereol. 2011; 25 (12): 1392–1397. http://doi.org/10.1111/j.1468-3083.2011.03979.x; Fazwi R., Chandran P.A., Ahmad T.S. Glomus tumour: a retrospective review of 15 years experience in a single institution. Malays. Orthop. J. 2011; 5 (3): 8–12. http://doi.org/10.5704/MOJ.1111.007; Kumar S., Tiwary S.K., More R. et al. Digital glomus tumor: An experience of 57 cases over 20 years. J. Family Med. Prim. Care. 2020; 9 (7): 3514–3517. http://doi.org/10.4103/jfmpc.jfmpc_446_20; Mashalkar N.S., Shetty N., Ellur S.R. Role of High Magnification Using Operative Microscope in Surgical Clearance of Glomus Tumor in Distal Phalanx: An Experience of 13 Cases. J. Cutan. Aesthet. Surg. 2022; 15 (3): 226–229. http://doi.org/10.4103/JCAS.JCAS_161_21; Аникин И.А., Комаров М.В. Гломусная опухоль (параганглиома) уха. Современное состояние проблемы. Литературный обзор. Российская оториноларингология. 2010; 4 (47): 100–114.; Свистушкин В.М., Шевчик Е.А., Мухамедов И.Т., Пшонкина Д.М. Опыт хирургического лечения гломусных опухолей. Вестник отриноларингологии. 2017; 1: 15–19. http://doi.org/10.17116/otorino201782115-19; Fan Z., Wu G., Ji B. et al. Color Doppler ultrasound morphology of glomus tumors of the extremities. SpringerPlus. 2016; 5: 1319. http://doi.org/10.1186/s40064-016-2883-0; Glazebrook K.N., Laundre B.J., Schiefer T.K., Inwards C.Y. Imaging features of glomus tumors. Skeletal Radiol. 2011; 40 (7): 855–862. http://doi.org/10.1007/s00256-010-1067-1; Lazor J.W., Guzzo T.J., Bing Z. et al. Glomus Tumor of the Kidney: A Case Report with CT, MRI, and Histopathological Findings. Open J. Urol. 2016; 6 (5): 80–85. http://doi.org/10.4236/oju.2016.65015; Tan T.J., Hayes M.M., Radigan J.P., Munk P.L. Glomus tumour of the colon: dynamic contrast-enhanced CT findings and review of the literature. Clin. Imaging. 2015; 39 (4): 714–716. http://doi.org/10.1016/j.clinimag.2015.02.015; Leger M., Patel U., Mandal R. et al. Glomangioma. Dermatol. Online. J. 2010; 16 (11): 11.; Ghaly R.F., Ring A.M. Supraclavicular glomus tumor, 20 year history of undiagnosed shoulder pain: a case report. Pain. 1999; 83 (2): 379–382. http://doi.org/10.1016/s0304-3959(99)00094-9; https://medvis.vidar.ru/jour/article/view/1356

الاتاحة: https://medvis.vidar.ru/jour/article/view/1356
https://doi.org/10.24835/1607-0763-1356

المؤلفون: Yu. A. Stepanova, O. I. Zhavoronkova, Ya. Ya. Gavrilov, O. A. Chekhoeva, A. A. Gritskevich, A. V. Glotov, Ю. А. Степанова, О. И. Жаворонкова, Я. Я. Гаврилов, О. А. Чехоева, А. А. Грицкевич, А. В. Глотов

المصدر: Medical Visualization; Том 27, № 1 (2023); 99-119 ; Медицинская визуализация; Том 27, № 1 (2023); 99-119 ; 2408-9516 ; 1607-0763

مصطلحات موضوعية: рецидив, multiple primary kidney cancer, radiofrequency ablation, dynamic monitoring, recurrence, первично-множественный рак почки, радиочастотная абляция, динамический мониторинг

وصف الملف: application/pdf

Relation: https://medvis.vidar.ru/jour/article/view/1309/779; Клиническая онкоурология / Под ред. Б.П. Матвеева. М.: Вердана, 2011. 934 с.; Wong M.C.S., Goggins W.B., Yip B.H.K. et al. Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries. Sci. Rep. 2017; 7 (1): 15698. http://doi.org/10.1038/s41598-017-15922-4.; Mahdavifar N., Mohammadian M., Ghoncheh M., Salehiniya H. Incidence, mortality and risk factors of kidney cancer in the world. WCRJ. 2018; 5 (1): e1013. http://doi.org/10.32113/wcrj_20183_1013; Аксель Е.М., Матвеев В.Б. Статистика злокачественных новообразований мочевых и мужских половых органов в России и странах бывшего СССР. Онкоурология. 2019; 5 (2): 15–24. http://doi.org/10.17650/1726-9776-2019-15-2-15-24; Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021; 71 (3): 209–249. http://doi.org/10.3322/caac.21660; Escudier B., Porta C., Schmidinger M. et al.; ESMO Guidelines Committee. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2019; 30 (5): 706–720. http://doi.org/10.1093/annonc/mdz056; Kümmerlin I.P., ten Kate F.J., Wijkstra H. et al. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU Int. 2008; 102 (8): 946–951. http://doi.org/10.1111/j.1464-410X.2008.07770.x; Nguyen M.M., Gill I.S., Ellison L.M. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J. Urol. 2006; 176 (6, Pt 1): 2397–2400. http://doi.org/10.1016/j.juro.2006.07.144; Gervais D.A., McGovern F.J., Arellano R.S., McDougal W.S., Mueller P.R. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am. J. Roentgenol. 2005; 185 (1): 64–71. http://doi.org/10.2214/ajr.185.1.01850064; Gervais D.A., Arellano R.S., McGovern F.J. et al. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. Am. J. Roentgenol. 2005; 185 (1): 72–80. http://doi.org/10.2214/ajr.185.1.01850072; Павлов А.Ю., Клименко А.А., Момджан Б.К., Иванов С.А. Радиочастотная интерстициальная термоабляция (РЧА) рака почки. Онкоурология. 2011; 2–3: 112–113.; Wendler J.J., Porsch M., Nitschke S. et al. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Contemp. Clin. Trials. 2015; 43: 10–19. http://doi.org/10.1016/j.cct.2015.05.002; Atwell T.D., Vlaminck J.J., Boorjian S.A. et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J. Vasc. Interv. Radiol. 2015; 26 (6): 792–729. http://doi.org/10.1016/j.jvir.2015.02.010; Yu J., Zhang X., Liu H. et al. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients. Radiology. 2020; 294 (3): 698–706. http://doi.org/10.1148/radiol.2020190919; Zlotta A.R., Wildschutz T., Raviv G. et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J. Endourol. 1997; 11 (4): 251–258. http://doi.org/10.1089/end.1997.11.251; Goldberg S.N., Gazelle G.S., Mueller P.R. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am. J. Roentgenol. 2000; 174: 323–331. http://doi.org/10.2214/ajr.174.2.1740323; Goldberg S.N., Dupuy D.E. Image-guided radiofrequency tumor ablation: challenges and opportunities: part I. J. Vasc. Interv. Radiol. 2001; 12: 1021–1032.; Yang Y., Chen S., Chen F. et al. Outcome of radiofrequency ablation over partial nephrectomy for small renal mass (; Matsumoto E.D., Johnson D.B., Ogan K. et al. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology. 2005; 65 (5): 877–881. http://doi.org/10.1016/j.urology.2004.12.011; Park S., Anderson J.K., Matsumoto E.D. et al. Radio-frequency ablation of renal tumors: intermediate-term results. J. Endourol. 2006; 20 (8): 569–573. http://doi.org/10.1089/end.2006.20.569; Hegarty N.J., Gill I.S., Desai M.M. et al. Probe-ablative nephron-sparing surgery: cryoablation versus radio-frequency ablation. Urology. 2006; 68 (1, Suppl.): 7–13. http://doi.org/10.1016/j.urology.2005.12.049; Zagoria R.J., Traver M.A., Werle D.M. et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Am. J. Roentgenol. 2007; 189 (2): 429–436. http://doi.org/10.2214/AJR.07.2258; Kim J.H., Kim T.H., Kim S.D. et al. Radiofrequency ablation of renal tumors: our experience. Korean J. Urol. 2011; 52 (8): 531–537. http://doi.org/10.4111/kju.2011.52.8.531; Lorber G., Glamore M., Doshi M. et al. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer. Urol. Oncol. 2014; 32 (7): 1017–1023. http://doi.org/10.1016/j.urolonc.2014.03.005; Lay A.H., Faddegon S., Olweny E.O. et al. Oncologic Efficacy of Radio Frequency Ablation for Small Renal Masses: Clear Cell vs Papillary Subtype. J. Urol. 2015; 194 (3): 653–657. http://doi.org/10.1016/j.juro.2015.03.115; Калпинский А.С., Алексеев Б.Я., Каприн А.Д., Воробьев Н.В., Нюшко К.М., Канукоев К.Ю., Вокач Д.С. Роль чрескожной радиочастотной абляции в лечении опухолей почек. Тюменский медицинский журнал. 2015; 17 (1): 39–44.; Siekiera J., Jasinski M., Mikołajczak W. Radiofrequency ablation of small renal masses in comorbid patients. Wideochir. Inne Tech. Maloinwazyjne. 2018; 13 (2): 212–214. http://doi.org/10.5114/wiitm.2018.74462; Johnson B.A., Sorokin I., Cadeddu J.A. Ten-Year Out-comes of Renal Tumor Radio Frequency Ablation. J. Urol. 2019; 201 (2): 251–258. http://doi.org/10.1016/j.juro.2018.08.045; Долгушин Б.И., Косырев Ю.В., Рампрабанант С. Радиочастотная аблация в онкологии. Практическая онкология. 2007; 8 (4): 219–227.; Salagierski M., Salagierski M.S. Radiofrequency ablation: a minimally invasive approach in kidney tumor management. Cancers (Basel). 2010; 2 (4): 1895–1900. http://doi.org/10.3390/cancers2041895; Gervais D.A., McGovern F.J., Arellano R.S. et al. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology. 2003; 226: 417–424. http://doi.org/10.1148/radiol.2262012062; Farrell M.A., Charboneau J.W., Callstrom M.R. et al. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. Am. J. Roentgenol. 2003; 181 (5): 1315–1317. http://doi.org/10.2214/ajr.181.5.1811315; Kurup A.N. Percutaneous Ablation for Small Renal Masses – Complications. Semin. Intervent. Radiol. 2014; 31 (1): 42–49. http://doi.org/10.1055/s-0033-1363842; Meloni M.F., Goldberg S.N., Livraghi T. et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. Am. J. Roentgenol. 2001; 177 (2): 375–380. http://doi.org/10.2214/ajr.177.2.1770375; Wah T.M., Irving H.C., Gregory W. et al. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int. 2014; 113 (3): 416–428. http://doi.org/10.1111/bju.12349; Kong W.T., Zhang W.W., Guo H.Q. et al. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Abdom. Imaging. 2011; 36 (3): 342–347. http://doi.org/10.1007/s00261-010-9665-x; Allard C.B., Coret A., Dason S. et al. Contrast-enhanced Ultrasonography for Surveillance of Radiofrequency-ablated Renal Tumors: A Prospective, Radiologist-blinded Pilot Study. Urology. 2015; 86 (6): 1174–1178. http://doi.org/10.1016/j.urology.2015.04.062; Ito K., Soga S., Seguchi K. et al. Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer. Oncol. Lett. 2017; 14 (1): 918–924. http://doi.org/10.3892/ol.2017.6262; Ogan K., Jacomides L., Dolmatch B.L. et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology. 2002; 60 (6): 954–895. http://doi.org/10.1016/s0090-4295(02)02096-4; Rane A., Stein R., Cadeddu J. Focal therapy for renal mass lesions: where do we stand in 2012? BJU Int. 2012; 109 (4): 491–492. http://doi.org/10.1111/j.1464-410X.2011.10855.x; Livraghi T., Goldberg S.N., Lazzaroni S. et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000; 214 (3): 761–768. http://doi.org/10.1148/radiology.214.3.r00mr02761; Cholley I., Correas J.M., Masson-Lecomte A. et al. Comparaison des résultats opératoires et oncologiques de la néphrectomie partielle et de l’ablation par radiofr quence pour traitement des tumeurs rénales chez les patients de plus de 75 ans [Comparison of operative and oncologic results between partial nephrectomy and radiofrequency ablation for treatment of renal tumors in patients older than 75]. Prog. Urol. 2018; 28 (1): 55–61. http://doi.org/10.1016/j.purol.2017.10.006 (In French); Yan S., Yang W., Zhu C.M. et al. Comparison among cryoablation, radiofrequency ablation, and partial nephrectomy for renal cell carcinomas sized smaller than 2 cm or sized 2–4 cm: A population-based study. Medicine (Baltimore). 2019; 98 (21): e15610. http://doi.org/10.1097/MD.0000000000015610; Rivero J.R., De La Cerda J. 3rd, Wang H. et al. Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients. J. Vasc. Interv. Radiol. 2018; 29 (1): 18–29. http://doi.org/10.1016/j.jvir.2017.08.013; Uhlig J., Strauss A., Rücker G. et al. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis. Eur. Radiol. 2019; 29 (3): 1293–1307. http://doi.org/10.1007/s00330-018-5660-3; Wilcox Vanden Berg R.N., Basourakos S.P., LaRussa S., McClure T.D. Management of the Small Renal Mass: a 2020 Update. Curr. Oncol. Rep. 2020; 22 (7): 69. http://doi.org/10.1007/s11912-020-00924-9; https://medvis.vidar.ru/jour/article/view/1309

الاتاحة: https://medvis.vidar.ru/jour/article/view/1309
https://doi.org/10.24835/1607-0763-1244

المؤلفون: I. S. Gruzdev, G. G. Karmazanovsky, M. G. Lapteva, K. A. Zamyatina, V. S. Tikhonova, E. V. Kondratyev, V. Yu. Struchkov, A. V. Glotov, I. S. Proskuryakov, D. V. Podluzhny, A. Sh. Revishvili, И. С. Груздев, Г. Г. Кармазановский, М. Г. Лаптева, К. А. Замятина, В. С. Тихонова, Е. В. Кондратьев, В. Ю. Стручков, А. В. Глотов, И. С. Проскуряков, Д. В. Подлужный, А. Ш. Ревишвили

المساهمون: The reported study was funded by RFBR, project number 20-315-90070., Исследование выполнено при финансовой поддержке РФФИ в рамках научного проекта № 20-315-90070.

المصدر: Medical Visualization; Том 26, № 4 (2022); 102-109 ; Медицинская визуализация; Том 26, № 4 (2022); 102-109 ; 2408-9516 ; 1607-0763

مصطلحات موضوعية: нейроэндокринная опухоль поджелудочной железы, texture analysis, renal cell carcinoma, metastases, pancreatic neuroendocrine tumor, текстурный анализ, почечно-клеточный рак, метастазы

وصف الملف: application/pdf

Relation: https://medvis.vidar.ru/jour/article/view/1279/765; Ouzaid I., Capitanio U., Staehler M. et al. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review. Eur. Urol. Oncol. 2019; 2 (2): 141–149. https://doi.org/10.1016/J.EUO.2018.08.028; Padala S.A., Barsouk A., Thandra K.C. et al. Epidemiology of Renal Cell Carcinoma. Wld J. Oncol. 2020; 11 (3): 79–87. https://doi.org/10.14740/WJON1279; Shah M.H., Goldner W.S., Benson A.B. et al. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2021; 19 (7): 839–867. https://doi.org/10.6004/JNCCN.2021.0032; Campbell S.C., Uzzo R.G., Karam J.A. et al. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II. J. Urol. 2021; 206 (2): 209–218. https://doi.org/10.1097/JU.0000000000001912; Almeida R.R., Lo G.C., Patino M. et al. Advances in Pancreatic CT Imaging. Am. J. Roentgenol. 2018; 211 (1): 52–66. https://doi.org/10.2214/AJR.17.18665; Lee N.J., Hruban R.H., Fishman E.K. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance. Abdom. Radiol. 2018; 43 (11): 3025–3034. https://doi.org/10.1007/s00261-018-1574-4; Sellner F. Observations on Solitary Versus Multiple Isolated Pancreatic Metastases of Renal Cell Carcinoma: Another Indication of a Seed and Soil Mechanism? Cancers. 2019; 11 (9): 1379. https://doi.org/10.3390/CANCERS11091379; Nogueira M., Dias S.C., Silva A.C. et al. Solitary pancreatic renal cell carcinoma metastasis. Autopsy. Case Reports. 2018; 8 (2): e2018023. https://doi.org/10.4322/ACR.2018.023; Akirov A., Larouche V., Alshehri S. et al. Treatment Options for Pancreatic Neuroendocrine Tumors. Cancers. 2019; 11 (6): 828. https://doi.org/10.3390/CANCERS11060828; Barthet M., Giovannini M., Lesavre N. et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: A prospective multicenter study. Endoscopy. 2019; 51 (9): 836–842. https://doi.org/10.1055/A-0824-7067/ID/JR17031-18; Fazio N., Kulke M., Rosbrook B. et al. Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib. Target. Oncol. 2021; 16 (1): 27–35. https://doi.org/10.1007/S11523-020-00784-0/FIGURES/4; Quhal F., Mori K., Bruchbacher A. et al. First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. Eur. Urol. Oncol. 2021; 4 (5): 755–765. https://doi.org/10.1016/J.EUO.2021.03.001; Powles T., Albiges L., Bex A. et al. ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma. Ann. Oncol. 2021; 32 (12): 1511–1519. https://doi.org/10.1016/J.ANNONC.2021.09.014; Gu D., Hu Y., Ding H. et al. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study. Eur. Radiol. 2019; 29 (12): 6880–6890. https://doi.org/10.1007/s00330-019-06176-x; Lin X., Xu L., Wu A. et al. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography. Acta Radiol. 60 (2019) 553–560. https://doi.org/10.1177/0284185118788895; Karmazanovsky G., Gruzdev I., Tikhonova V. et al. Computed tomography-based radiomics approach in pancreatic tumors characterization. Radiol. Medica. 2021; 126: 1388–1395. https://doi.org/10.1007/S11547-021-01405-0/FIGURES/1; van der Pol C.B., Lee S., Tsai S. et al. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features. Abdom. Radiol. 2019; 44(3): 992–999. https://doi.org/10.1007/s00261-018-01889-x; Nioche C., Orlhac F., Boughdad S. et al. Lifex: A freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018; 78 (16): 4786–4789. https://doi.org/10.1158/0008-5472.CAN-18-0125; Gruzdev I.S., Zamyatina K.A., Tikhonova V.S. et al. Reproducibility of CT texture features of pancreatic neuroendocrine neoplasms. Eur. J. Radiol. 2020; 133: 109371. https://doi.org/10.1016/j.ejrad.2020.109371; Kang T.W., Kim S.H., Lee J. et al. Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication. Eur. J. Radiol. 2015; 84 (11): 2089–2096. https://doi.org/10.1016/J.EJRAD.2015.08.007; Lyu H.-L., Cao J.-X., Wang H.-Y. et al. Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging. Abdom. Radiol. 2018; 43 (10): 2712–2720. https://doi.org/10.1007/s00261-018-1539-7; Ambrosetti M.C., Zamboni G.A., Fighera A., Mansueto G. Pancreatic metastases from renal neoplasms and neuroendocrine pancreatic tumours: is a differential diagnosis possible with CT? Hell. J. of Radiol. 2019; 4 (3). 17–21. https://doi.org/10.36162/HJR.V4I3.295; https://medvis.vidar.ru/jour/article/view/1279

الاتاحة: https://medvis.vidar.ru/jour/article/view/1279
https://doi.org/10.24835/1607-0763-1247

المؤلفون: Т. А. Shchegolkova, N. Yu. Germanovich, А. А. Pechetov, О. I. Gavoronkova, А. V. Glotov, Т. А. Щеголькова, Н. Ю. Германович, А. А. Печетов, О. И. Жаворонкова, А. В. Глотов

المصدر: Malignant tumours; Том 12, № 4 (2022); 50-57 ; Злокачественные опухоли; Том 12, № 4 (2022); 50-57 ; 2587-6813 ; 2224-5057

مصطلحات موضوعية: дифференциальная диагностика опухолей молочной железы, malignant phyllodes tumor, fibroadenoma, differential diagnosis of breast tumors, злокачественная листовидная опухоль, фиброаденома

وصف الملف: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/1018/715; Корженкова Г. П., Касымова А. А. Злокачественная листовидная опухоль на примере клинического случая /// Вестник рентгенологии и радиологии .– 2021 .– Т. 102 .– № 3 .– С. 178–182 .– DOI:10.20862/0042-4676-2021-102-3-178-182 .– EDN QDSSXG.; Волченко А. А., Пак Д. Д., Усов Ф. Н., Фетисова Е. Ю. Клинические наблюдения. Гигантская листовидная опухоль молочной железы : клинические наблюдения. Журнал «Онкохирургия», 2012, том 4, № 2.; Zhang Y, Kleer CG. Phyllodes Tumor of the Breast : Histopathologic Features, Differential Diagnosis, and Molecular / Genetic Updates. Arch Pathol Lab Med. 2016 Jul; 140 (7) : 665–71. doi:10.5858/arpa.2016–0042-RA. PMID : 27362571.; Ван Шу. Диссертация на соискание ученой степени кандидата медицинских наук. Выявление и лечение неэпителиальных злокачественных опухолей молочной железы. Санкт-Петербург 2017. Стр 134. 5.; Roberts N, Runk DM. Aggressive malignant phyllodes tumor. Int J Surg Case Rep. 2015; 8C : 161–5. doi:10.1016/j.ijscr.2014.12.041. Epub 2015 Jan 15. PMID : 25697402; PMCID : PMC4353966.).; Денчик Д. А,. Воротников И. К,. Любченко Л. Н [и др.] // Особенности листовидных опухолей / Опухоли женской репродуктивной системы .– 2010 .– № 3 .– С. 21–23 .– EDN NCKWWF.; Rageth CJ, O'Flynn EAM, Pinker K, Kubik-Huch RA, Mundinger A, Decker T, Tausch C, Dammann F, Baltzer PA, Fallenberg EM, Foschini MP, Dellas S, Knauer M, Malhaire C, Sonnenschein M, Boos A, Morris E, Varga Z. Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat. 2019 Apr; 174 (2) : 279–296. doi:10.1007/s10549-018-05071-1. Epub 2018 Nov 30. Erratum in : Breast Cancer Res Treat. 2019 Jul; 176 (2) : 481–482. PMID : 30506111; PMCID : PMC6538569.; Lissidini G, Mulè A, Santoro A, Papa G, Nicosia L, Cassano E, Ashoor AA, Veronesi P, Pantanowitz L, Hornick JL, Rossi ED. Malignant phyllodes tumor of the breast : a systematic review. Pathologica. 2022 Apr; 114 (2) : 111–120. doi:10.32074/1591-951X-754. Epub 2022 Apr 13. PMID : 35414723.; Зикиряходжаев А. Д., Широких И. М. Харченко Н. В [и др.] Филлоидные опухоли молочных желез. Современное состояние проблемы // Исследования и практика в медицине .– 2017 .– Т. 4 .– № 2 .– С. 13–22 .– DOI:10.17709/2409-2231-2017-4-2-2.; Баранова И. Б., Размахаев Г. С. Листовидная (филлоидная) злокачественная опухоль молочной железы в материале тонкоигольной аспирационной пункции. Клинический случай / Новости клинической цитологии России .– 2021 .– Т. 25 .– № 4 .– С. 14–18 .– DOI:10.24412/1562-4943-2021-4-0003 .– EDN OSYEKL.; 140 (7) : 665–71. doi:10.5858/arpa.2016–0042-RA. PMID : 27362571.).; Lissidini G, Mulè A, Veronesi P, et al. Malignant phyllodes tumor of the breast : a systematic review. Pathologica 2022; 114 : 111–120.; Григорук О. Г.,. Богатырев В. Н,. Лазарев А. Ф [и др.] Цитологическая диагностика листовидных опухолей и сарком молочной железы // Маммология .– 2005 .– № 1 .– С. 23–28.; Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes : a review of surgical options // Surgery .– 1989 .– Vol. 105 .– P. 141–147).; Высоцкая И. В,. Летягин В. П, Черенков В. Г. [и др.] Клинические рекомендации РООМ по профилактике РМЖ, дифференциальной диагностике, лечению, предопухолевых и доброкачественных заболеваний молочных желез. Клинические рекомендации общероссийской общественной организации Роом по диагностике и лечению РМЖ .– Москва : Издательский дом «АБВ-пресс», 2017 .– С. 91–124 .– EDN HUABVJ. 15.; Lim, S. Z., Selvarajan, S., Thike, A. A. et al. Breast sarcomas and malignant phyllodes tumours : comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes. Breast Cancer Res Treat 159, 229–244 (2016). https://doi.org/10.1007/s10549-016-3946-1.; Chia Y, Thike AA, Cheok PY, Yong-Zheng Chong L, Man-Kit Tse G, Tan PH. Stromal keratin expression in phyllodes tumours of the breast : a comparison with other spindle cell breast lesions. J Clin Pathol. 2012; 65 (4) : 339–347. doi:10.1136/jclinpath-2011-200377.; Ходорович О. С., Солодкий В. А., Калинина -Масри А. А. [и др.] Филлоидные опухоли молочной железы. От диагностики до патоморфологического исследования /// Опухоли женской репродуктивной системы .– 2021 .– Т. 17 .– № 3 .– С. 69–78 .– DOI:10.17650/1994-4098-2021-17-3-69-78 .– EDN WBVRTY.; Ben Hassouna J, Damak T, Gamoudi A, Chargui R, Khomsi F, Mahjoub S, Slimene M, Ben Dhiab T, Hechiche M, Boussen H, Rahal K. Phyllodes tumors of the breast : a case series of 106 patients. Am J Surg. 2006 Aug; 192 (2) : 141–7. doi:10.1016/j.amjsurg.2006.04.007. PMID : 16860620.; Высоцкая И. В., Летягин В. П., Черенков В. Г. [и др.] Клинические рекомендации Российского общества онкомаммологов по профилактике рака молочной железы, дифференциальной диагностике, лечению предопухолевых и доброкачественных заболеваний молочных желез. Опухоли женской репродуктивной системы .– 2016 .– Т. 12 .– № 3 .– С. 43–52 .– EDN WZWGXB.; Клинические рекомендации «Саркомы мягких тканей» (утв. Минздравом России). 2020. https://bazanpa.ru/minzdrav-rossii-klinicheskie-rekomendatsii-ot01012020-h4758471.; https://www.malignanttumors.org/jour/article/view/1018

الاتاحة: https://www.malignanttumors.org/jour/article/view/1018
https://doi.org/10.18027/2224-5057-2022-12-4-50-57

المؤلفون: S. V. Glotov

المصدر: Zoodiversity, Vol 56, Iss 5 (2022)

مصطلحات موضوعية: coleoptera, staphylinidae, aleocharinae, gyrophaena, taxonomy, russia, taiwan, Zoology, QL1-991

Relation: https://ojs.akademperiodyka.org.ua/index.php/Zoodiversity/article/view/358; https://doaj.org/toc/2707-725X; https://doaj.org/toc/2707-7268; https://doaj.org/article/9cc95a1431fe4ccca303efaf4ee119e0

الاتاحة: https://doi.org/10.15407/zoo2022.05.373
https://doaj.org/article/9cc95a1431fe4ccca303efaf4ee119e0

المؤلفون: Kh. A. Ayvazyan, B. N. Gurmikov, R. O. Anvari, Yu. A. Stepanova, D. V. Kalinin, A. V. Glotov, V. S. Shirokov, L. A. Marinova, M. V. Kadirova, E. S. Malyshenko, A. V. Zhao

المصدر: Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 27:125-134

مصطلحات موضوعية: Hepatology, Gastroenterology, Surgery

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4e9035b88f90a3daf96cbbcdd3189a49
https://doi.org/10.16931/1995-5464.2022-4-125-134

المؤلفون: S. V. Glotov, K. V. Hushtan

المصدر: Biosystems Diversity, Vol 28, Iss 4, Pp 364-369 (2020)

مصطلحات موضوعية: fauna, new species, new records, state museum of natural history, lviv, Science

Relation: https://ecology.dp.ua/index.php/ECO/article/view/1065; https://doaj.org/toc/2519-8513; https://doaj.org/toc/2520-2529; https://doaj.org/article/22146c478bd04b92b126e687f109bb8b

الاتاحة: https://doi.org/10.15421/012046
https://doaj.org/article/22146c478bd04b92b126e687f109bb8b

المؤلفون: Anatoly P. Savelyev, Sergey V. Glotov, Mikhail N. Chugunov, Rail R. Salikhov

المصدر: RUDN Journal of Ecology and Life Safety, Vol 28, Iss 1, Pp 35-46 (2020)

مصطلحات موضوعية: probability of fire, safe evacuation of people, regulatory requirements, fire hazards, automatic fire alarm system, warning system and management of evacuation of people in case of fire, individual fire risk, Environmental sciences, GE1-350

Relation: https://journals.rudn.ru/ecology/article/viewFile/24582/18598; https://doaj.org/toc/2313-2310; https://doaj.org/toc/2408-8919; https://doaj.org/article/0a3b1b609aa641798d3409639167759f

الاتاحة: https://doi.org/10.22363/2313-2310-2020-28-1-35-46
https://doaj.org/article/0a3b1b609aa641798d3409639167759f

المؤلفون: A. P. Savelyev, S. V. Glotov, M. N. Chugunov, S. A. Enaleeva

المصدر: Russian Engineering Research. 42:S121-S123

مصطلحات موضوعية: Mechanical Engineering, Industrial and Manufacturing Engineering

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::718518e08e9b89b441e8ae6c2ec6b88b
https://doi.org/10.3103/s1068798x23010264

المؤلفون: A. P. Savelyev, S. V. Glotov, M. N. Chugunov, S. A. Enaleeva

المصدر: Russian Engineering Research. 42:701-704

مصطلحات موضوعية: Mechanical Engineering, Industrial and Manufacturing Engineering

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c3a7d579e47d6145c2b4eb6c2ed02a41
https://doi.org/10.3103/s1068798x22070255

المؤلفون: A. G. Kriger, A. V. Smirnov, S. V. Berelavichus, D. S. Gorin, N. N. Vetsheva, Ja. I. Nerestjuk, D. V. Kalinin, A. V. Glotov

المصدر: Исследования и практика в медицине, Vol 3, Iss 3, Pp 49-58 (2016)

مصطلحات موضوعية: duodenal dystrophy, groove pancreatitis, paraduodenal pancreatitis, chronic pancreatitis, Medicine

وصف الملف: electronic resource

Relation: https://www.rpmj.ru/rpmj/article/view/150; https://doaj.org/toc/2410-1893

URL الوصول: https://doaj.org/article/4812fd11f5324608838a60dd4725434c

المؤلفون: K. Kh. Lomovtseva, Yu. S. Gal’china, A. V. Glotov, D. V. Kalinin, A. V. Chzhao, Yu. A. Kovalenko, G. G. Karmazanovsky, К. Х. Ломовцева, Ю. С. Гальчина, А. В. Глотов, Д. В. Калинин, А. В. Чжао, А. Ю. Коваленко, Г. Г. Кармазановский

المصدر: Medical Visualization; № 2 (2018); 84-93 ; Медицинская визуализация; № 2 (2018); 84-93 ; 2408-9516 ; 1607-0763

مصطلحات موضوعية: гепатобилиарный контрастный препарат, malignant transformation, magnetic resonance imaging, hepatobiliary contrast agent, малигнизация, магнитно-резонансная томография

وصف الملف: application/pdf

Relation: https://medvis.vidar.ru/jour/article/view/550/470; Сурков А.Н., Намазова-Баранова Л.С., Потапов А.С., Савостьянов К.В., Пушков А.А., Никитин А.Г., Полякова С.И., Рязанов М.В., Кустова О.В., Барский В.И., Степанян М.Ю. Случай множественных аденом печени у подростка с тяжелым течением гликогеновой болезни типа Ib. Вестник РАМН. 2014; 11–12: 54–59.; Vijay A., Elaffandi A., Khalaf H. Hepatocellular adenoma: An update. Wld J. Hepatol. 2015; 7 (25): 2603.; Mamada Y., Onda M., Tajiri T., Akimaru K., Yoshida H., Taniai N., Mineta S., Hirakata A., Hirose Y. Liver cell adenoma in a 26-year-old man. J. Nippon Med. School. 2001; 68 (6): 516–519.; Herman P., Pugliese V., Machado M. A., Montagnini A. L., Salem M. Z., Bacchella T., D’Albuquerque L. A., Saad W.A., Machado M. C., Pinotti H. W. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. Wld J. Surg. 2000; 24 (3): 372–376.; Toso C., Majno P., Andres A., Rubbia-Brandt L., Berney T., Buhler L., Morel P., Mentha G. Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. Wld J. Gastroenterol. 2005; 11 (36): 56–91.; Dokmak S., Paradis V., Vilgrain V., Sauvanet A., Farges O., Valla D., Bedossa P., Belghiti J. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009; 137 (5): 1698–1705. DOI:10.1053/j.gastro.2009.07.061.; Stoot J.H., Coelen R.J., De Jong M.C., Dejong C.H. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB. 2010; 12 (8): 509–522. DOI:10.1111/j.1477-2574.2010.00222.x.; Farges O., Ferreira N., Dokmak S., Belghiti J., Bedossa P., Paradis V. Changing trends in malignant transformation of hepatocellular adenoma. Gut. 2011; 60 (1): 85–89. DOI:10.1136/gut.2010.222109.; Zucman Rossi J., Jeannot E., Van Nhieu J. T., Scoazec J. Y., Guettier C., Rebouissou S., Bacq Y., Leteurtre E., Paradis V., Michalak S., Wendum D., Chiche L., Fabre M., Mellottee L., Laurent C., Partensky C., Castaing D., Zafrani E.S., Laurent-Puig P., Balabaud C., Bioulac-Sage P. Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006; 43 (3): 515–524. DOI:10.1002/hep.21068.; Lade A.G., Monga S.P. Beta-catenin signaling in hepatic development and progenitors: Which way does the WNT blow? Developmental Dynamics. 2011; 240 (3): 486–500. DOI:10.1002/dvdy.22522.; Bioulac-Sage P., Balabaud C., Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Digest. Surg. 2010; 27 (1): 39–45. DOI:10.1159/000268406.; Toiyama Y., Inoue Y., Yasuda H., Yoshiyama S., Araki T., Miki C., Kusunoki M. Hepatocellular adenoma containing hepatocellular carcinoma in a male patient with familial adenomatous polyposis coli: Report of a case. Surg. Today. 2011; 41 (10): 1442. DOI:10.1007/s00595-010-4451-5.; Nault J.C., Bioulac-Sage P., Zucman-Rossi J. Hepatocellular benign tumors – from molecular classification to personalized clinical care. Gastroenterology. 2013; 144 (5): 888–902. DOI:10.1053/j.gastro.2013.02.032.; Bioulac Sage P., Laumonier H., Couchy G., Le Bail B., Sa Cunha A., Rullier A., Laurent C., Blanc J.F., Cubel G., Trillaud H., Zucman Rossi J., Balabaud C., Saric J. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009; 50 (2): 481–489. DOI:10.1002/hep.22995.; Bioulac-Sage P., Sempoux C., Balabaud C. Hepatocellular adenoma: classification, variants and clinical relevance. Seminars in Diagn. Pathol. 2017; 34 (20): 112–125. DOI:10.1053/j.semdp.2016.12.007.; Ronald M., Woodfield J., McCall J., Koea J. Hepatic adenomas in male patients. HPB. 2004; 6 (1): 25–27. DOI:10.1080/13651820310020846.; Vázquez J.J., Marigil M.A. Liver-cell adenoma in an epileptic man on barbiturates. Histol. Histopathol. 1989; 4 (3): 301–303.; Tazawa K., Yasuda M., Ohtani Y., Makuuchi H., Osamura R.Y. Multiple hepatocellular adenomas associated with long-term carbamazepine. Histopathology. 1999; 35 (1): 92–94. DOI:10.1046/j.1365-2559.1999.0728g.x.; Ferko A., Bedrna J., Nozicka J. Pigmented hepatoc ellular adenoma of the liver caused by long-term use of phenobarbital. Rozhl chir. 2003; 82 (4): 192–195.; Seki A., Inoue T., Maegaki Y., Sugiura C., Toyoshima M., Akaboshi S., Ohno K. Polycystic ovary syndrome and hepatocellular adenoma related to long-term use of sodium valproate in a young woman. No to hattatsu. 2006; 38 (3): 205–208.; Lautz T.B., Finegold M.J., Chin A.C., Superina R.A. Giant hepatic adenoma with atypical features in a patient on oxcarbazepine therapy. J. Pediatr. Surg. 2008; 43 (4): 751–754. DOI:10.1016/j.jpedsurg.2007.11.036.; Lee P.U., Roberts L.R., Kaiya J.K., Lee C.U. Hepatic adenomas associated with anti-epileptic drugs: a case series and imaging review. Abdom. Imaging. 2010; 35 (2): 208–211.; Bioulac-Sage P., Sempoux C., Possenti L., Frulio N., Laumonier H., Laurent C., Chiche L., Blanc J. F., Saric J., Trillaud H., Le Bail B., Balabaud C. Pathological diagnosis of hepatocellular cellular adenoma according to the clinical context. Int. J. Hepatol. 2013; 2013: 253261. DOI:10.1155/2013/253261.; Davis M., Portmann B., Searle M., Wright R., Williams R. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br. Med J. 1975; 4 (5995): 496–498.; Deneve J. L., Pawlik T. M., Cunningham S., Clary B., Reddy S., Scoggins C. R., Martin C.G. Angelica M., Staley C.A., Choti M.A., Jarnagin, W. R., Schulick R.D. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann. Surg. Oncol. 2009; 16 (3): 640–648. DOI:10.1245/s10434-008-0275-6.; Farges O., Dokmak S. Malignant transformation of liver adenoma: an analysis of the literature. Digest. Surg. 2010; 27 (1): 32–38. DOI:10.1159/000268405.; An S. L., Wang L. M., Rong W. Q., Wu F., Sun W., Yu, W. B., Feng L., Liu F.Q., Tian F., Wu J. X. Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers. Chinese J. Cancer. 2015; 34 (3): 17. DOI:10.1186/s40880-015-0014-x.; Micchelli S.T., Vivekanandan P., Boitnott J.K., Pawlik T.M., Choti M.A., Torbenson M. Malignant transformation of hepatic adenomas. Modern Pathol. 2008; 21 (4): 491. DOI:10.1038/modpathol.2008.8.; Laumonier H., Bioulac-Sage P., Laurent C., ZucmanRossi J., Balabaud C., Trillaud H. Hepatocellular aden omas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008; 48 (3): 808–818. DOI:10.1002/hep.22417.; van Aalten S.M., Thomeer M.G., Terkivatan T., Dwarkasing R.S., Verheij J., de Man R., Ijzermans J.N. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011; 261 (1): 172–181. DOI:10.1148/radiol.11110023.; Ronot M., Bahrami S., Calderaro J., Valla D.C., Bedossa P., Belghti J., Vilgrain V., Paradis, V. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011; 53 (4): 1182–1191. DOI:10.1002/hep.24147.; Лукьянченко А.Б., Медведева Б.М. Современные возможности лучевой диагностики гепатоцеллюлярных аденом (обзор литературы и собственные наблюдения). Медицинская визуализация. 2013; (1): 33–43.; Yoneda N., Matsui O., Kitao A., Kozaka K., Kobayashi S., Sasaki M. Yoshida K., Inoue D., Minami T., Gabata, T. Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. Radiographics. 2016; 36 (7): 2010–2027. DOI:10.1148/rg.2016160037.; Agarwal S., Fuentes-Orrego J. M., Arnason T., Misdraji J., Jhaveri K.S., Harisinghani M., Hahn P. F. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid–enhanced MRI. Am. J. Roentgenol. 2014; 203 (4): 408–414. DOI:10.2214/AJR.13.12251.; Fukusato T., Soejima Y., Kondo F., Inoue M., Watanabe M., Takahashi Y., Aso T., Uozaki H., Sano K., Sanada Y., Niki T. Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. Hepatol. Res. 2015; 45 (10). DOI:10.1111/hepr.12453.; Kwok W.Y., Hagiwara S., Nishida N., Watanabe T., Sakurai T., Ida H., Minami Y.,Takita M., Minami T., Iwanishi M., Chishina H., Kono M., Ueshima K., Komeda Y., Arizumi T., Enoki E., Nakai T., Kumabe T., Nakashima O., Kondo F., Kudo M. Malignant transformation of hepatocellular adenoma. Oncology. 2017; 92(1): 16–28. DOI:10.1159/000451012.; Agnello F., Ronot M., Valla D.C., Sinkus R., Van Beers B.E., Vilgrain V. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology. 2012; 262 (2): 511–519. DOI:10.1148/radiol.11110922.; Lee S.A., Lee .H., Jung W.Y., Lee ., Choi J.W., Kim K.A, Park C.M. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOBDTPA enhanced MRI: initial experience. Magn. Reson. Imaging. 2011; 29(1): 83–90. DOI:10.1016/j.mri.2010.07.019.; Descottes B., Glineur D., Lachachi F., Valleix D., Paineau J., Hamy A., Morino M., Bismuth H., Castaing D., Savier E., Honore P., Detry O., Legrand M., Azagra J.S., Goergen M., Ceuterick M., Marescaux J., Mutter D., Hemptinne B., Troisi R., Weerts J., Dallemagne B., Jehaes C., Gelin M., Donckier V., Aerts R., Topal B., Bertrand C., Mansvelt B., Van Krunckelsven L., Herman D., Kint M., Totte E., Schockmel R., GigoT J.F. Laparoscopic liver resection of benign liver tumors. Surg. Endosc. Intervent. Techn. 2003; 17 (1): 23–30. DOI:10.1007/s00464-002-9047-8.; Khanna M., Ramanathan S., Fasih N., Schieda N., Virmani V., McInnes M.D. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights into imaging. 2015; 6 (3): 347–362. DOI:10.1007/s13244-015-0399-8.; https://medvis.vidar.ru/jour/article/view/550

الاتاحة: https://medvis.vidar.ru/jour/article/view/550
https://doi.org/10.24835/1607-0763-2018-2-84-93

المؤلفون: A. P. Savelyev, S. V. Glotov, M. N. Chugunov, S. A. Enaleeva

المصدر: Russian Engineering Research. 42:373-375

مصطلحات موضوعية: Mechanical Engineering, Industrial and Manufacturing Engineering

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::aae41fafd09f0a6d6648f18592a007c2
https://doi.org/10.3103/s1068798x22040268

المؤلفون: G. R. Kasyan, M. Y. Gvozdev, Y. A. Kupriyanov, A. V. Glotov, R. V. Stroganov

المصدر: Вестник урологии, Vol 0, Iss 3, Pp 63-68 (2014)

مصطلحات موضوعية: recurrent urinary incontinence, suburethral sling procedure, tvt, tot, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

Relation: https://www.urovest.ru/jour/article/view/53; https://doaj.org/toc/2308-6424

URL الوصول: https://doaj.org/article/dd323c114b3b4992bcbc221fe7d75f2a

المؤلفون: Sergey V. Glotov, Mikhail Nikolaevich Chugunov, Anatoly Petrovich Savelyev, Svetlana Anatolyevna Enaleeva

المصدر: Nexo Revista Científica. 34:270-279

مصطلحات موضوعية: business.industry, Environmental resource management, Environmental science, Fire safety, business, Disease cluster

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3d1236117ed6b57f7b162abbe4535ced
https://doi.org/10.5377/nexo.v34i01.11305

المؤلفون: S. V. Glotov

المصدر: Ukrainian Entomological Journal. 18:36-40

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e4110a2b99843ffdb29a428c33d87293
https://doi.org/10.15421/282005